We are live on ! Find out more
BIIB icon

Biogen
BIIB

1,014 hedge funds and large institutions have $59B invested in Biogen in 2017 Q3 according to their latest regulatory filings, with 99 funds opening new positions, 380 increasing their positions, 356 reducing their positions, and 68 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more funds holding in top 10

Funds holding in top 10: 23 → 38 (+15)

46% more first-time investments, than exits

New positions opened: 99 | Existing positions closed: 68

16% more capital invested

Capital invested by funds: $50.9B → $59B (+$8.14B)

2% more funds holding

Funds holding: 992 → 1,014 (+22)

1.38% more ownership

Funds ownership: 87.77% → 89.15% (+1.4%)

7% more repeat investments, than reductions

Existing positions increased: 380 | Existing positions reduced: 356

22% less call options, than puts

Call options by funds: $974M | Put options by funds: $1.24B

Holders
1,014
Holders Change
+22
Holders Change %
+2.22%
% of All Funds
25.28%
Holding in Top 10
38
Holding in Top 10 Change
+15
Holding in Top 10 Change %
+65.22%
% of All Funds
0.95%
New
99
Increased
380
Reduced
356
Closed
68
Calls
$974M
Puts
$1.24B
Net Calls
-$269M
Net Calls Change
-$87M

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$513M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$310M
3
Ameriprise
Ameriprise
Minnesota
+$178M
4
AQR Capital Management
AQR Capital Management
Connecticut
+$167M
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$133M

Top Sellers

1
BlackRock
BlackRock
New York
-$344M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$206M
3
Renaissance Technologies
Renaissance Technologies
New York
-$190M
4
SIG
Senator Investment Group
New York
-$136M
5
Citadel Advisors
Citadel Advisors
Florida
-$119M
Name Holding Trade Value Shares
Change 		Change in
Stake
MFW
826
Mosaic Family Wealth
Missouri
$275K +$8K +27 +3%
SWA
827
Sutton Wealth Advisors
Florida
$275K – – –
ICOA
828
Investment Centers of America
North Dakota
$274K +$253K +854 New
SC
829
Savant Capital
Illinois
$273K +$10.7K +36 +4%
MCM
830
Maple Capital Management
Vermont
$272K – – –
GCC
831
Guardian Capital (Canada)
Ontario, Canada
$272K +$257K +869 New
HCA
832
Harbour Capital Advisors
Virginia
$270K – – –
AWA
833
ARS Wealth Advisors
Florida
$269K +$254K +858 New
DLA
834
Douglas Lane & Associates
New York
$267K -$4.44K -15 -2%
NCM
835
Northside Capital Management
Oregon
$267K – – –
CS
836
Credential Securities
$266K -$33.2K -112 -12%
WPC
837
Waters Parkerson & Co
Louisiana
$266K -$6.81K -23 -3%
FMLI
838
Fukoku Mutual Life Insurance
Japan
$266K +$14.8K +50 +6%
FWM
839
Focused Wealth Management
New York
$266K +$111K +375 +79%
PWLP
840
Prio Wealth Limited Partnership
Massachusetts
$263K – – –
TFCP
841
Twin Focus Capital Partners
Massachusetts
$263K – – –
RCA
842
Rex Capital Advisors
Rhode Island
$263K +$5.03K +17 +2%
SFG
843
SevenBridge Financial Group
Pennsylvania
$262K -$12.4K -42 -5%
KF
844
Krilogy Financial
Missouri
$261K +$150K +505 +153%
FLII
845
First Long Island Investors
New York
$260K – – –
GT
846
Greenleaf Trust
Michigan
$260K +$246K +831 New
PIM
847
Penobscot Investment Management
Massachusetts
$258K – – –
CANC
848
Culbertson A N & Co
Virginia
$257K – – –
PA
849
Probity Advisors
Texas
$252K +$11K +37 +5%
ACM
850
Adalta Capital Management
New York
$250K – – –
32 33
34
35 36

BIIB Hedge Fund Activity: Q3 2017 in Review

1,014 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Biogen (BIIB) for Q3 2017, worth a combined $59B — up 16% from $50.9B a quarter earlier.

Buyers outnumbered sellers: 99 funds opened new BIIB positions and 68 closed out — a net gain of 31 holders — while 380 added to existing stakes and 356 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $513M. The largest seller was BlackRock, cutting an estimated $344M.

  • 1,014 institutional investors held Biogen (BIIB) as of Q3 2017, up from 992 in Q2 2017.
  • Funds reported $59B of Biogen stock for Q3 2017, up 16% quarter-over-quarter.
  • 99 funds opened new Biogen positions in Q3 2017 and 68 closed out, a net change of +31 holders.
  • The largest Biogen buyer in Q3 2017 was T. Rowe Price Associates, an estimated $513M added.
  • The largest Biogen seller in Q3 2017 was BlackRock, an estimated $344M sold.

Based on aggregated 13F filings for Q3 2017.